Oxidized Low-Density Lipoprotein Accumulation in Macrophages Impairs Lipopolysaccharide-Induced Activation of AKT2, ATP Citrate Lyase, Acetyl-Coenzyme A Production, and Inflammatory Gene H3K27 Acetylation.


Journal

ImmunoHorizons
ISSN: 2573-7732
Titre abrégé: Immunohorizons
Pays: United States
ID NLM: 101708159

Informations de publication

Date de publication:
01 Jan 2024
Historique:
received: 06 11 2023
accepted: 06 11 2023
medline: 9 1 2024
pubmed: 9 1 2024
entrez: 9 1 2024
Statut: ppublish

Résumé

The accumulation of lipid and the formation of macrophage foam cells is a hallmark of atherosclerosis, a chronic inflammatory disease. To better understand the role of macrophage lipid accumulation in inflammation during atherogenesis, we studied early molecular events that follow the accumulation of oxidized low-density lipoprotein (oxLDL) in cultured mouse macrophages. We previously showed that oxLDL accumulation downregulates the inflammatory response in conjunction with downregulation of late-phase glycolysis. In this study, we show that within hours after LPS stimulation, macrophages with accumulated oxLDL maintain early-phase glycolysis but selectively downregulate activation of AKT2, one of three AKT isoforms. The inhibition of AKT2 activation reduced LPS-induced ATP citrate lyase activation, acetyl-CoA production, and acetylation of histone 3 lysine 27 (H3K27ac) in certain inflammatory gene promoters. In contrast to oxLDL, multiple early LPS-induced signaling pathways were inhibited in macrophages with accumulated cholesterol, including TBK1, AKT1, AKT2, MAPK, and NF-κB, and early-phase glycolysis. The selective inhibition of LPS-induced AKT2 activation was dependent on the generation of mitochondrial oxygen radicals during the accumulation of oxLDL in macrophages prior to LPS stimulation. This is consistent with increased oxidative phosphorylation, fatty acid synthesis, and oxidation pathways found by comparative transcriptomic analyses of oxLDL-loaded versus control macrophages. Our study shows a functional connection between oxLDL accumulation, inactivation of AKT2, and the inhibition of certain inflammatory genes through epigenetic changes that occur soon after LPS stimulation, independent of early-phase glycolysis.

Identifiants

pubmed: 38193847
pii: 266605
doi: 10.4049/immunohorizons.2300101
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-73

Informations de copyright

Copyright © 2024 The Authors.

Auteurs

Kenneth K Y Ting (KKY)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

Pei Yu (P)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.

Mudia Iyayi (M)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.

Riley Dow (R)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

Sharon J Hyduk (SJ)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.

Eric Floro (E)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.

Hisham Ibrahim (H)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Saraf Karim (S)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

Chanele K Polenz (CK)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Daniel A Winer (DA)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Division of Endocrinology and Metabolism, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Minna Woo (M)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Division of Endocrinology and Metabolism, Department of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada.

Jonathan Rocheleau (J)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
Banting and Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada.
Department of Physiology, University of Toronto, Toronto, Ontario, Canada.

Jenny Jongstra-Bilen (J)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Myron I Cybulsky (MI)

Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Classifications MeSH